1. Home
  2. KBH vs VERA Comparison

KBH vs VERA Comparison

Compare KBH & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

N/A

Current Price

$49.17

Market Cap

3.4B

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$35.05

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KBH
VERA
Founded
1957
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
KBH
VERA
Price
$49.17
$35.05
Analyst Decision
Hold
Strong Buy
Analyst Count
14
10
Target Price
$56.17
$81.30
AVG Volume (30 Days)
720.3K
1.8M
Earning Date
03-24-2026
05-06-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
N/A
EPS
0.96
N/A
Revenue
$4,547,002,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.23
$472.48
P/E Ratio
$51.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.03
$22.72
52 Week High
$68.41
$56.05

Technical Indicators

Market Signals
Indicator
KBH
VERA
Relative Strength Index (RSI) 28.59 46.52
Support Level $44.03 $29.66
Resistance Level $58.83 $37.13
Average True Range (ATR) 1.49 1.70
MACD -0.67 0.12
Stochastic Oscillator 2.64 38.42

Price Performance

Historical Comparison
KBH
VERA

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: